ArticleAmerican journal of respiratory and critical care medicine2022
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study.
Registry-linked trialOpen access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06900062 (The C-BRIDGE Study), which is not on this map. Cited by 108 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
31.0field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
Who cites it
108 citing papers in PubMed, 1 synthesis or guideline pooled it, 221 citations in OpenAlex.
- Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.Respiration; international review of thoracic diseases · 2026Guideline
- Blood Eosinophil Count, Disease Severity, and Exacerbation Risk in Korean Patients with Bronchiectasis: A Retrospective Cohort Study.Tuberculosis and respiratory diseases · 2026Article
- The clinical impact of bronchoscopy: balancing microbiology and inflammatory endotyping.ERJ open research · 2026Article
- Age-Specific Considerations in Bronchiectasis Management: Focus on Older Adults with Emphasis on Anti-inflammatory Treatment.Drugs & aging · 2026Review
- Article
- Type 2 inflammation, bronchiectasis and clinical trials: expanding from MAHALE.ERJ open research · 2026Article
- The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.ERJ open research · 2026Article
- Benralizumab in bronchiectasis: results from the phase 3 MAHALE study.ERJ open research · 2026Article
- Article
- Targeting Inflammation in Bronchiectasis.Drugs · 2026Review
- Fractional Exhaled Nitric Oxide in Children with Non-Cystic Fibrosis Bronchiectasis: Associations with Etiology, Lung Function, and CT Extent.Pediatric reports · 2026Article
- Article
- The importance of symptoms in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Brensocatib-Another Therapeutic "Window of Opportunity" for Patients with Bronchiectasis.Journal of clinical medicine · 2026Review
- Radiological Phenotypes of Bronchiectasis Based on Airway Generation.Biomedicines · 2026Article
- Integrated traditional Chinese medicine and Western medicine strategies for the treatment of bronchiectasis: a comprehensive review.Chinese medicine · 2026Review
- Mortality rate and affecting factors in bronchiectasis patients: a 10-year retrospective cohort study from Turkey.BMC pulmonary medicine · 2026Article
- Connecting the Airways: Current Trends in United Airway Diseases.Journal of personalized medicine · 2026Review
- Precision diagnostics in bronchiectasis: current advances in imaging, microbiology, biomarkers, and digital health.Frontiers in medicine · 2026Review
- Fractional Exhaled Nitric Oxide (FeNO) as a Biomarker of Lower Airway Eosinophilic Inflammation: Benefits and Limitations.Journal of inflammation research · 2026Review
48 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
19 authors at 13 institutions in 8 countries.
Amelia ShoemarkDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.ORCID 0000-0001-7360-6060
Michal ShteinbergPulmonology Institute and Cystic Fibrosis Center, Carmel Medical Center, Haifa, Israel.
Anthony De SoyzaPopulation and Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Charles S HaworthCambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, United Kingdom.
Hollian RichardsonDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.
Yonghua GaoDepartment of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-8140-1679
Lidia PereaHospital Clinic of Barcelona, University of Barcelona, Centro de Investigación Biomédica en Red Enfermedades Respiratorias, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Alison J DickerDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.ORCID 0000-0002-4791-3259
Pieter C GoeminneDepartment of Respiratory Disease, AZ Nikolaas, Sint-Niklaas, Belgium.
Erin CantDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.
Eva PolverinoPneumology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Josje AltenburgDepartment of Respiratory Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Holly R KeirDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.
Michael R LoebingerRoyal Brompton Hospital and Imperial College London, London, United Kingdom.
Francesco BlasiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
Tobias WelteDepartment of Pulmonary Medicine and Infectious Diseases, Hannover University School of Medicine, Hannover, Germany.
Oriol SibilaHospital Clinic of Barcelona, University of Barcelona, Centro de Investigación Biomédica en Red Enfermedades Respiratorias, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Stefano AlibertiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
James D ChalmersDivision of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.ORCID 0000-0001-5514-7868
University of Dundee · GBCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESAmsterdam University Medical Centers · NLCarmel Medical Center · ILFreeman Hospital · GBHumanitas University · ITMedizinische Hochschule Hannover · DERoyal Brompton Hospital · GBTongji University · CNUniversity of Milan · ITUniversity of Ulster · GBVall d'Hebron Hospital Universitari · ESVlaamse Vereniging voor Obstetrie en Gynaecolo · BE
Funding
Chief Scientist Office SCAF/17/03
Abstract
PubMed holds no abstract for this paper.
Indexed as
AsthmaBronchiectasisEosinophilsHumansLeukocyte CountRNA, Ribosomal, 16SRNA, Ribosomal, 16Sbronchiectasiseosinophilexacerbationsmicrobiome
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT06900062ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.